Research Database

246 studies found

Positive

130

52.8%

Negative

6.9%

Inconclusive

37.4%

Page 11 of 13

PositiveAnimal Study - Veterinary Clinical Trial

The role of the endocannabinoid system in eating disorders: pharmacological implications

2012

AnorexiaAnorexia NervosaBehavioral Disorders+2

InconclusiveReview/Other

Functional polymorphism in the GPR55 gene is associated with anorexia nervosa

2011

Anorexia

PositiveDouble Blind Clinical Trial

Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial

2011

Cancer

PositiveReview/Other

The cannabinoid receptor agonist THC attenuates weight loss in a rodent model of activity-based anorexia

2011

Anorexia Nervosa

InconclusiveAnimal Study - Veterinary Clinical Trial

The Endocannabinoid System as Pharmacological Target Derived from Its CNS Role in Energy Homeostasis and Reward. Applications in Eating Disorders and Addiction

2011

Anorexia Nervosa

InconclusiveReview/Other

Subjective and physiological effects after controlled Sativex and oral THC administration

2011

Addiction

InconclusiveReview/Other

Brain type 1 cannabinoid receptor availability in patients with anorexia and bulimia nervosa

2011

Anorexia

PositiveAnimal Study -

Fish oil promotes survival and protects against cognitive decline in severely undernourished mice by normalizing satiety signals

2011

Anorexia

InconclusiveAnimal Study -

Activity-based anorexia in C57/BL6 mice: effects of the phytocannabinoid, Delta9-tetrahydrocannabinol (THC) and the anandamide analogue, OMDM-2

2010

Anorexia Nervosa

InconclusiveReview/Other

Elevated cannabinoid 1 receptor mRNA is linked to eating disorder related behavior and attitudes in females with eating disorders

2009

Anorexia

InconclusiveReview/Other

Association of CNR1 and FAAH endocannabinoid gene polymorphisms with anorexia nervosa and bulimia nervosa: evidence for synergistic effects

2009

Anorexia Nervosa

InconclusiveReview/Other

Cannabinoids for the treatment of dementia

2009

Anorexia

PositiveReview/Other

Leptin, ghrelin, and endocannabinoids: potential therapeutic targets in anorexia nervosa

2009

Anorexia Nervosa

PositiveReview/Other

Cannabinoids in Chronic Pain and Palliative Care

2008

Addiction

InconclusiveReview/Other

Lack of association of genetic variants in genes of the endocannabinoid system with anorexia nervosa

2008

Anorexia Nervosa

PositiveAnimal Study - Veterinary Clinical Trial

Evaluation of oral cannabinoid-containing medications for the management of interferon and ribavirin-induced anorexia, nausea and weight loss in patients treated for chronic hepatitis C virus.

2008

Anorexia

PositiveReview/Other

Anorexia of aging in long term care: is dronabinol an effective appetite stimulant?--a pilot study.

2007

Anorexia

PositiveReview/Other

Cannabinoids in health and disease

2007

Addiction - Alcohol

PositiveReview/Other

Use of Dronabinol Improves Appetite and Reverses Weight Loss in HIV/AIDS-Infected Patients.

2007

Anorexia

InconclusiveDouble Blind Clinical Trial

Comparison Of Orally Administered Cannabis Extract And Delta-9-tetrahydrocannabinol In Treating Patients With Cancer-related Anorexia-cachexia Syndrome: A Multicenter, Phase III, Randomized, Double-blind, Placebo-controlled Clinical Trial From The Cannabis-In-Cachexia-Study-Group

2006

Anorexia

Command Palette

Research Database

The role of the endocannabinoid system in eating disorders: pharmacological implications

Functional polymorphism in the GPR55 gene is associated with anorexia nervosa

Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial

The cannabinoid receptor agonist THC attenuates weight loss in a rodent model of activity-based anorexia

The Endocannabinoid System as Pharmacological Target Derived from Its CNS Role in Energy Homeostasis and Reward. Applications in Eating Disorders and Addiction

Subjective and physiological effects after controlled Sativex and oral THC administration

Brain type 1 cannabinoid receptor availability in patients with anorexia and bulimia nervosa

Fish oil promotes survival and protects against cognitive decline in severely undernourished mice by normalizing satiety signals

Activity-based anorexia in C57/BL6 mice: effects of the phytocannabinoid, Delta9-tetrahydrocannabinol (THC) and the anandamide analogue, OMDM-2

Elevated cannabinoid 1 receptor mRNA is linked to eating disorder related behavior and attitudes in females with eating disorders

Association of CNR1 and FAAH endocannabinoid gene polymorphisms with anorexia nervosa and bulimia nervosa: evidence for synergistic effects

Cannabinoids for the treatment of dementia

Leptin, ghrelin, and endocannabinoids: potential therapeutic targets in anorexia nervosa

Cannabinoids in Chronic Pain and Palliative Care

Lack of association of genetic variants in genes of the endocannabinoid system with anorexia nervosa

Evaluation of oral cannabinoid-containing medications for the management of interferon and ribavirin-induced anorexia, nausea and weight loss in patients treated for chronic hepatitis C virus.

Anorexia of aging in long term care: is dronabinol an effective appetite stimulant?--a pilot study.

Cannabinoids in health and disease

Use of Dronabinol Improves Appetite and Reverses Weight Loss in HIV/AIDS-Infected Patients.

Comparison Of Orally Administered Cannabis Extract And Delta-9-tetrahydrocannabinol In Treating Patients With Cancer-related Anorexia-cachexia Syndrome: A Multicenter, Phase III, Randomized, Double-blind, Placebo-controlled Clinical Trial From The Cannabis-In-Cachexia-Study-Group